Clinical trial
A Phase II Study of SU011248 in Advanced Hepatocellular Carcinoma
NCT00361309 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of SU011248 in Advanced Hepatocellular Carcinoma
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 30, 2006
- Completion date
- March 31, 2009
- Enrollment
- 34 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
hepatocellular carcinoma, liver cancer